Finding better ways to heal broken bones using special cells
Identifying the superior ossification pathway for tissue engineered approaches to long bone repair
This study is looking at how special cells called mesenchymal stromal cells can help broken bones heal better and faster by grouping them in a way that boosts their healing power, which could lead to new treatments that make recovery easier for people with fractures.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11026452 on NIH RePORTER |
What this research studies
This research focuses on improving the healing process for broken bones by using mesenchymal stromal cells (MSCs), which have the ability to develop into different types of cells needed for bone repair. The study investigates how MSCs can be grouped into spheroids to enhance their effectiveness in promoting bone growth and healing. By exploring the optimal conditions and factors that stimulate these cells, the research aims to develop new treatments that could reduce complications and improve recovery times for patients with fractures. The approach includes testing the delivery of growth factors in lower doses to minimize side effects while maximizing healing potential.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from bone fractures that are at risk of nonunion or slow healing.
Not a fit: Patients with stable fractures that are expected to heal normally without intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for bone fractures, reducing healing time and improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using MSCs for bone healing, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Leach, J. Kent — University of California at Davis
- Study coordinator: Leach, J. Kent
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.